Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reply to Correspondence

Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Chen-Hua Liu, Yu-Ping Chang

Clin Mol Hepatol. 2025;31(2):e232-e233. Published online February 26, 2025

DOI: https://doi.org/10.3350/cmh.2025.0203

View: 257 Download: 16

Correspondence

Correspondence to letter to the editor on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”

Hee Yeon Kim, Miyoung Choi, Dae Won Jun

Clin Mol Hepatol. 2025;31(1):e105-e107. Published online November 4, 2024

DOI: https://doi.org/10.3350/cmh.2024.0937

View: 666 Download: 22

Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”

Hee Yeon Kim, Miyoung Choi, Dae Won Jun

Clin Mol Hepatol. 2025;31(1):e48-e51. Published online September 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0777

View: 881 Download: 24

Editorial

Essential tools for assessing advanced fibrosis in metabolic dysfunction-associated steatotic liver disease: Editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”

Won Sohn

Clin Mol Hepatol. 2025;31(1):277-280. Published online October 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0823

View: 1066 Download: 37 Crossref: 1

Spotting undiagnosed significant liver fibrosis in the general population: impact on subsequent clinical care: Editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”

Nana Peng, Mary Yue Wang, Sherlot Juan Song, Terry Cheuk-Fung Yip

Clin Mol Hepatol. 2025;31(1):256-260. Published online September 3, 2024

DOI: https://doi.org/10.3350/cmh.2024.0737

View: 880 Download: 57 Crossref: 1

Original Article

Assessment of the postoperative prognosis in patients with hepatocellular carcinoma using vibration-controlled transient elastography: A systemic review and meta-analysis

Jung Hwan Yu, Ji Won Han, Young Ju Suh, Young Eun Chon, Hee Yeon Kim, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Dae Won Jun, Han Ah Lee, Mi Na Kim

Clin Mol Hepatol. 2024;30(Suppl):S186-S198. Published online August 21, 2024

DOI: https://doi.org/10.3350/cmh.2024.0366

View: 1740 Download: 91 Crossref: 1

Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysis

Jihyun An, Young Eun Chon, Gunho Kim, Mi Na Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Miyoung Choi, Dae Won Jun, Seung Up Kim, Ji Won Han, Young-Joo Jin

Clin Mol Hepatol. 2024;30(Suppl):S134-S146. Published online August 21, 2024

DOI: https://doi.org/10.3350/cmh.2024.0586

View: 2457 Download: 135 Web of Science: 2 Crossref: 1

Special Issue

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, Beom Kyung Kim, Young-Joo Jin, Seung-seob Kim, Minjong Lee, Han Ah Lee, Yuri Cho, Hee Yeon Kim, Yu Rim Shin, Jung Hwan Yu, Moon Young Kim, YoungRok Choi, Young Eun Chon, Eun Ju Cho, Eun Joo Lee, Sang Gyune Kim, Won Kim, Dae Won Jun, Seung Up Kim, on behalf of The Korean Association for the Study of the Liver (KASL)

Clin Mol Hepatol. 2024;30(Suppl):S5-S105. Published online August 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0506

View: 3106 Download: 227 Web of Science: 7 Crossref: 11

Editorial

Refining Portal Hypertension Assessment: The Clinical Significance of Spleen Stiffness Measurement in the Baveno VII Era

Do Seon Song

Received March 13, 2025 Accepted March 20, 2025

DOI: https://doi.org/10.3350/cmh.2025.0296 [Accepted]

View: 161 Download: 16

Original Article

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease

Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim

Received December 30, 2024 Accepted April 2, 2025

DOI: https://doi.org/10.3350/cmh.2024.1183 [Accepted]

View: 282 Download: 37

1 |

Viewed By 8335	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7317	MAFLD: How is it different from NAFLD?
Viewed By 5293	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4950	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4523	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 291	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search